Definium Therapeutics grants options for 93,320 shares to six new employees
DFTX•Definium Therapeutics granted six newly hired non-executive employees options to purchase 93,320 common shares under its 2026 Inducement Plan.
1. Option grant
The options have an effective grant date of October 26, 2026, after Compensation Committee approval on October 23. They vest over four years, with 25% vesting on the first anniversary and the remaining 75% in substantially equal monthly installments over three years, subject to continued employment.
